跳至主要内容
临床试验/CTRI/2023/06/053636
CTRI/2023/06/053636尚未招募Unknown

Assessment Of Pre-treatment Neutrophil Lymphocyte Ratio Among Cervical Cancer Patients And Its Association with Stages Of Cervical Cancer (FIGO), Sociodemographic, Lifestyle And Reproductive Factors.

Vardhman Mahavir Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients with positive biopsy report of cervical carcinoma at any stage of the disease

排除标准

  • Patients who donâ??t have a record of their Pre Treatment Neutrophil lymphocyte Ratio (NLR).
  • Severely ill patients not able to converse.
  • Patients suffering from sepsis.
  • Patients with a positive biopsy for blood cancer.
  • Patients with a history of tuberculosis.
  • Patients with severe wounds.
  • Any other severe inflammation except cervical cancer.
  • Patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities.
  • Any medication or indication that may interfere with the interpretation of study results and, in the judgment of the study personnel, would make the subject inappropriate for inclusion.
  • Patients with history of severe allergies.

研究者

发起方
Vardhman Mahavir Medical College

相似试验